SRTS: Sensus Healthcare, Inc. Stock

by  •  • Comments Off on SRTS: Sensus Healthcare, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 78.60
Enterprise Value ($M) 56.54
Book Value ($M) 55.83
Book Value / Share 3.38
Price / Book 1.41
NCAV ($M) 50.40
NCAV / Share 3.06
Price / NCAV 1.56

Profitability (mra)
Return on Invested Capital (ROIC) 0.12
Return on Assets (ROA) 0.12
Return on Equity (ROE) 0.13

Liquidity (mrq)
Quick Ratio 7.36
Current Ratio 9.64

Balance Sheet (mrq) ($M)
Current Assets 56.74
Assets 62.16
Liabilities 6.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 41.81
Operating Income 8.09
Net Income 6.65
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -0.83
Cash from Investing -0.28
Cash from Financing 0.01

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-07 13G/A Solot Edwin Lee 7.60 -18.78

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 39,914 108,544 36.77
2025-04-28 12,471 84,423 14.77
2025-04-25 6,291 25,751 24.43
2025-04-24 4,612 59,672 7.73

(click for more detail)

Similar Companies
SMLR – Semler Scientific, Inc. SMTI – Sanara MedTech Inc.
SNOA – Sonoma Pharmaceuticals, Inc. SSII – SS Innovations International, Inc.
SSKN – STRATA Skin Sciences, Inc.


Financial data and stock pages provided by
Fintel.io